Published in Gut on December 01, 1993
Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut (2002) 1.92
Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study. Gut (2000) 1.06
Inflammation and oxidative stress in gastroesophageal reflux disease. J Clin Biochem Nutr (2007) 1.03
Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway. Biochem J (2004) 0.97
Adaptation of esophageal mucosa to acid- and pepsin-induced damage: role of nitric oxide and epidermal growth factor. Dig Dis Sci (1997) 0.93
Characteristics of patients with columnar-lined Barrett's esophagus and risk factors for progression to esophageal adenocarcinoma. World J Gastroenterol (2005) 0.85
Loss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: clues from a study of Barrett's oesophagus. J Clin Pathol (2006) 0.79
Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter? Dig Dis Sci (2011) 0.77
Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Therap Adv Gastroenterol (2012) 0.76
Low grade dysplasia in Barrett's esophagus: Should we worry? World J Gastrointest Pathophysiol (2014) 0.75
Chronic peptic ulcer of the oesophagus and 'oesophagitis'. Br J Surg (1950) 9.92
Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature (1990) 3.20
Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol (1990) 2.29
Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus. Gut (1992) 1.31
Abnormal expression of growth regulatory factors in Barrett's oesophagus. Clin Sci (Lond) (1991) 1.18
Epidermal growth factor receptors in the oesophagus. Gut (1992) 1.15
Epidermal growth factor in the oesophagus. Gut (1992) 1.01
Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression. Gut (1992) 0.99
Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma. Scand J Gastroenterol (1992) 0.96
Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis. Am J Gastroenterol (1993) 0.94
Expression of epidermal growth factor, transforming growth factor alpha and their receptor in gastro-oesophageal diseases. Dig Dis (1993) 0.90